부산대학교 도서관

Volkmann, Elizabeth R ; Varga, John ; Blazar, Bruce R ; Pavletic, Steven Z

In The Lancet Rheumatology November 2024 6(11):e740-e743

Schoemans, Hélène, Prof; Stienissen, Elke, ML; Goris, Kathy, MS; Stewart, Susan K, BA; Cowden, Meredith, MA LPCC-S; Arnahoutova, Kristina, MPharm; Pavletic, Steven Z, Prof; Greinix, Hildegard, Prof; Barata, Anna, PhD; Warwick, Lorna, BEd; Bolanos, Natacha; Barbosa, Isabel, PhD; Bouguet, Guy, BSc; Lhenry-Yvon, Isabelle, PhD; Manninen, Riikka-Leena, MS; Pavukova, Simona, MD; Tavori, Guy, MSW; van Amerongen, Marleen; Lawitschka, Anita, MD PhD; Schultz, Kirk R, Prof; Wolff, Daniel, Prof; Herrmann, Anne, Prof

The Lancet Haematology. 12(3):e214-e223

Schulz, Eduard ; Pirsl, Filip ; Beshensky, David ; Holtzman, Noa G. ; Steinberg, Seth M. ; Pavletic, Steven Z

In Blood 15 November 2022 140 Supplement 1:10554-10556

Volkmann ER; Department of Medicine, Division of Rheumatology, David Geffen School of Medicine, University of California Los Angeles.; Goklemez S; Department of Medicine, University of Cincinnati College of Medicine, Cincinnati, Ohio.; Varga J; Department of Medicine, Division of Rheumatology, University of Michigan, Ann Arbor.; Blazar BR; Department of Pediatrics, Division of Blood and Bone Marrow Transplant & Cellular Therapy, University of Minnesota, Minneapolis.; Pavletic SZ; Immune Deficiency and Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Publisher: John Wiley & Sons Inc Country of Publication: United States NLM ID: 101740025 Publication Model: Print Cited Medium: Internet ISSN: 2578-5745 (Electronic) Linking ISSN: 25785745 NLM ISO Abbreviation: ACR Open Rheumatol Subsets: PubMed not MEDLINE

El Jurdi, Najla; Blazar, Bruce R; Pavletic, Steven Z

Transplantation

Bredeson, Christopher N ; Pavletic, Steven Z

In Best Practice & Research Clinical Haematology 2004 17(2):327-343

Strong J; Dermatology Branch, National Institutes of Health, Bethesda, Maryland.; Saito Y; Dermatology Branch, National Institutes of Health, Bethesda, Maryland.; Trang W; Biomedical Translational Research Information System, National Institutes of Health Clinical Center, Bethesda, Maryland.; Beri A; Biomedical Translational Research Information System, National Institutes of Health Clinical Center, Bethesda, Maryland.; Firek A; Dermatology Branch, National Institutes of Health, Bethesda, Maryland.; Munoz SM; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, Maryland.; Hickstein DD; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Childs RW; National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.; Dimitrova D; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Kanakry JA; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Kanakry CG; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Cowen EW; Dermatology Branch, National Institutes of Health, Bethesda, Maryland.; Castelo-Soccio L; Dermatology Branch, National Institutes of Health, Bethesda, Maryland.; Brownell I; Dermatology Branch, National Institutes of Health, Bethesda, Maryland.; Center for Immuno-Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Publisher: American Medical Association Country of Publication: United States NLM ID: 101589530 Publication Model: Print Cited Medium: Internet ISSN: 2168-6084 (Electronic) Linking ISSN: 21686068 NLM ISO Abbreviation: JAMA Dermatol Subsets: MEDLINE; In Process

Markova A; Dermatology Service, Department of Medicine, Memorial Sloan Kettering Cancer, New York, New York; Weill Cornell Medicine, New York, New York. Electronic address: markovaa@mskcc.org.; Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.; Modi B; Division of Dermatology, City of Hope, Duarte, California.; Baumrin E; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.; Rosenstein RK; Center for Discovery and Innovation and Department of Internal Medicine, Hackensack Meridian School of Medicine, Hackensack University Medical Center, Nutley, New Jersey.; Tkaczyk ER; Department of Veterans Affairs, Nashville, Tennessee; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.; Lehman JS; Departments of Dermatology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.; Inamoto Y; Department of BMT and Cellular Therapy, Fujita Health University School of Medicine, Toyoake, Aichi, Japan.; Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Pediatrics, University of Washington, Seattle, Washington.; Schultz KR; Michael Cuccione Childhood Cancer Research Program, British Columbia Children's Hospital Research Institute, University of British Columbia, Vancouver, British Columbia, Canada.; Pidala JA; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.; Martin P; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington; Department of Medicine, University of Washington, Seattle, Washington.; Pusic I; Division of Oncology, Washington University School of Medicine, Siteman Cancer Center, St. Louis, Missouri; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Goklemez S; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Division of Hematology Oncology, Department of Internal Medicine, University of Cincinnati Medical Center, Cincinnati, Ohio.; Stockmann C; University of Zurich, Institute of Anatomy, Zurich, Switzerland.; Pinal-Fernandez I; Muscle Disease Section, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland; Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland.; Paczesny S; Hollings Cancer Center and Department of Pharmacology and Immunology, Medical University of South Carolina, Charleston, South Carolina.; Harris A; Pediatric Transplant and Cellular Therapies, Memorial Sloan Kettering Cancer Center, New York, New York.; Ponce DM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York; Weill Cornell Medical College, New York, New York.; Holtzman NG; Division of Transplantation and Cell Therapy, Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida.; Jurdi NE; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Cowen EW; Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Im, Annie ; Wolff, Daniel ; Cutler, Corey ; Zeiser, Robert ; Shah, Nirav N. ; Tan, Ming Tony ; Sanz, Jaime ; Ali, Haris ; Milone, Giuseppe ; Law, Arjun D. ; Russo, Domenico ; Wagner, Eva-Maria ; Ivanova, Olga ; Hou, Kevin ; Bleam, Maureen ; Morariu-Zamfir, Rodica ; Pavletic, Steven Z

In Blood 15 November 2022 140 Supplement 1:1870-1871

Wolff D; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany. Electronic address: daniel.wolff@ukr.de.; Cutler C; Division of Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mercep I; Department of Internal Medicine, School of Medicine, University Hospital Center Zagreb, University of Zagreb, Zagreb, Croatia.; Jaki T; Faculty of Informatics and Data Science, Division of Computational Statistics, University of Regensburg, Germany.; Robertson DS; MRC Biostatistics Unit, University of Cambridge, Cambridge, UK.; Schultz KR; BC Children's Hospital Research Institute and University of BC, Vancouver, British Columbia, Canada.; Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Martin PJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, Washington.; Pavletic SZ; National Cancer Institute, Center for Cancer Research, Immune Deficiency Cellular Therapy Program, National Institutes of Health, Bethesda, Maryland.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

Hartigan CR; Division of Blood and Marrow Transplant and Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN.; McDonald-Hyman C; Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN.; Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Blazar BR; Division of Blood and Marrow Transplant and Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN.

Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 0132144 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-6080 (Electronic) Linking ISSN: 00411337 NLM ISO Abbreviation: Transplantation Subsets: MEDLINE

McNeil, Andrew; Parks, Kelsey; Pogharian, Michael; Cowen, Edward W; Lehman, Julia; Lee, Stephanie J; Pavletic, Steven Z; Dawant, Benoit M; Tkaczyk, Eric R

Journal of Clinical & Translational Science; 2025 Supplemenet, Vol. 9, p9-10, 2p

Goklemez, Sencer; Hasni, Sarfaraz; Hakim, Frances T; Muraro, Paolo A; Pirsl, Filip; Rose, Jeremy; Memon, Sarfraz; Fowler, Daniel F; Steinberg, Seth M; Baker, Eva H; Panch, Sandya R; Gress, Ronald; Illei, Gabor G; Lipsky, Peter E; Pavletic, Steven Z

Rheumatology. Aug2022, Vol. 61 Issue 8, p3317-3328. 12p.

Costa-da-Silva AC; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Sharma R; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Aure MH; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Martin D; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Kedei N; Collaborative Protein Technology Resource, OSTR, Office of the Director, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Killanin DF; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Javaid A; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Boksa FA; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Mody DP; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Nguyen JT; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Ganesan SM; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Dodge JT; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Kim CH; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Kao-Hsieh M; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.; Kleiner DE; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Kanakry CG; Center for Immuno-Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Pavletic SZ; Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.; Mays JW; National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA.

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Lee SJ; Clinical Research Division and Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington. Electronic address: sjlee@fredhutch.org.; Williams KM; Aflac Blood and Cancer Center, Children's Healthcare of Atlanta, Department of Pediatrics, Emory University, Atlanta Georgia.; Sarantopoulos S; Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University Medical Center, Durham, North Carolina.; Kitko CL; Vanderbilt University Medical Center, Nashville, Tennessee.; Cutler C; Division of Transplantation and Cellular Therapy, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pidala J; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.; Hill GR; Clinical Research Division and Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington.; DeFilipp Z; Hematopoietic Cell Transplant and Cellular Therapy Program, Massachusetts General Hospital, Boston, Massachusetts.; Greinix HT; Division of Hematology, Medical University, Graz, Austria.; Wolff D; Department of Internal Medicine III, University Hospital Regensburg, Germany.; Paczesny S; Hollings Cancer Center, Department of Immunology, Medical University of South Carolina, Charleston, South Carolina.; Cuvelier GDE; Pediatric Oncology and Transplantation, Alberta Children's Hospital, University of Calgary, Calgary, Alberta, Canada.; Schultz KR; BC Children's Hospital Research Institute and University of BC, Vancouver, British Columbia, Canada.; Pavletic SZ; National Cancer Institute, Center for Cancer Research, Immune Deficiency Cellular Therapy Program, National Institutes of Health, Bethesda, Maryland. Electronic address: pavletics@outlook.com.

Publisher: Elsevier Inc Country of Publication: United States NLM ID: 101774629 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-6367 (Electronic) Linking ISSN: 26666367 NLM ISO Abbreviation: Transplant Cell Ther Subsets: MEDLINE

El Jurdi N; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Waldman MA; Kidney Disease Section, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, USA.; Schulz E; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Myeloid Malignancies Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Mina A; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Myeloid Malignancies Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Li G; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Carpenter A; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Theis JD; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.; Sethi S; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.; Caza T; Arkana Laboratories, Little Rock, Arkansas, USA.; Seshan SV; Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, New York, USA.; Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.; Myeloid Malignancies Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 0372544 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2141 (Electronic) Linking ISSN: 00071048 NLM ISO Abbreviation: Br J Haematol Subsets: MEDLINE; In Process

Schulz E; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Myeloid Malignancies Program, Center for Cancer Research, National Institutes of Health, Bethesda, MD.; Curtis LM; Mount Auburn Hematology Associates, Cambridge, MA.; Holtzman NG; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Sylvester Comprehensive Cancer Center, Miami, FL.; Steinberg SM; Biostatistics and Data Management Section, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Wloka K; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Ostojic A; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Mina A; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Myeloid Malignancies Program, Center for Cancer Research, National Institutes of Health, Bethesda, MD.; El Jurdi N; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Pirsl F; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Carpenter A; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Golagha M; Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Sirajuddin A; Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, MD.; Heller T; Liver Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD.; Shaffer BC; Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Hakim FT; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Rubin JS; Laboratory of Cellular and Molecular Biology, Center for Cancer Research, National Institutes of Health, Bethesda, MD.; Gress RE; Experimental Transplantation and Immunotherapy Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Myeloid Malignancies Program, Center for Cancer Research, National Institutes of Health, Bethesda, MD.

Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

Sharma R; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.; Holtzman NG; Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Pusic I; Division of Oncology, Washington University School of Medicine, St. Louis, MO.; Cutler C; Division of Transplantation and Cellular Therapy, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Treister N; Division of Oral Medicine and Dentistry, Brigham and Women's Hospital, Boston, MA.; Mehta RS; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Alousi AS; Division of Cancer Medicine, Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX.; Vigneswaran N; Department of Diagnostic and Biomedical Sciences, The University of Texas Health Science Center, School of Dentistry, Houston, TX.; Javaid A; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.; Boksa F; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.; Mody DP; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.; Costa-da-Silva AC; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.; Schueller O; Sanofi, Cambridge, MA.; Macé S; Sanofi, Vitry-Sur-Seine, France.; Yao Y; Sanofi, Cambridge, MA.; Ji R; Sanofi, Bridgewater, NJ.; Hu B; Sanofi, Bridgewater, NJ.; Marshall K; Sanofi, Bridgewater, NJ.; Blazar BR; Division of Blood and Marrow Transplant & Cellular Therapy, Department of Pediatrics, University of Minnesota, Minneapolis, MN.; Lee SJ; Division of Clinical Research, Fred Hutchinson Cancer Center, Seattle, WA.; Pavletic SZ; Immune Deficiency Cellular Therapy Program, National Cancer Institute, National Institutes of Health, Bethesda, MD.; Mays JW; Oral Immunobiology Unit, National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

Pidala J; Department of Blood and Marrow Transplantation and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL, United States of America.; Carpenter PA; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America.; Department of Pediatrics, University of Washington, Seattle, WA, United States of America.; Onstad L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America.; Pavletic SZ; National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, United States of America.; Hamilton BK; Blood and Marrow Transplant Program, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, United States of America.; Chen GL; University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.; Farhadfar N; Division of Hematology/Oncology, University of Florida College of Medicine, Gainesville, FL, United States of America.; Hall M; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America.; Lee SJ; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States of America.; Department of Medicine, University of Washington, Seattle, WA, United States of America.

Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

Mitchell SA; Outcomes Research Branch, Healthcare Delivery Research Program, National Cancer Institute, Bethesda, MD, United States.; Hunter R; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Fry A; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Pavletic SZ; Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Widemann BC; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.; Wiener L; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, United States.

Publisher: Frontiers Research Foundation Country of Publication: Switzerland NLM ID: 101550902 Publication Model: eCollection Cited Medium: Print ISSN: 1664-1078 (Print) Linking ISSN: 16641078 NLM ISO Abbreviation: Front Psychol Subsets: PubMed not MEDLINE